Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine
Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the third leading cause of cancer death. Approximately 15% of GC is associated with Epstein−Barr virus (EBV). GC is largely incurable with a dismal five-year survival rate. There is an urgent need to identify new therape...
Main Authors: | Xiangyu Ke, Qingsong Qin, Tianyi Deng, Yueyan Liao, Shou-Jiang Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/2/365 |
Similar Items
-
The role of microbiota in the development and treatment of gastric cancer
by: Yiwen Wang, et al.
Published: (2023-09-01) -
Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis
by: Ahmad Tavakoli, et al.
Published: (2020-06-01) -
Tenovin-1 Ameliorates Renal Fibrosis in High-Fat-Diet-Induced Diabetic Nephropathy via Antioxidant and Anti-Inflammatory Pathways
by: Amit Kundu, et al.
Published: (2022-09-01) -
Association of tumors having Epstein–Barr virus in surrounding lymphocytes with poor prognosis
by: Norikazu Yogi, et al.
Published: (2023-01-01) -
Methylation of drug resistance‐related genes in chemotherapy‐sensitive Epstein–Barr virus‐associated gastric cancer
by: Hirofumi Ohmura, et al.
Published: (2020-01-01)